What is CheckEye?
Š cloud-based solution to detect diabetic retinopathy using photographic images of eye fundus through the ML\AI algorithm.
Problem
According to the International Diabetes Federation, over 537 million people are living with diabetes globally and this number is growing at an alarming rate. Most of these people will develop some form of retinopathy causing reduced vision or, in severe cases, blindness.
āEveryone with diabetes is at risk of losing vision.ā
– International Diabetes Federation
The World Health Organisation defines diabetic retinopathy as the leading cause of blindness in the working age population in most countries. However, early diagnosis and timely treatment of diabetic retinopathy can prevent sight impairment and blindness. Interventions that are both cost-saving and feasible include screening and treatment for retinopathy.
approximately 2% of people become blind,
and about 10% develop severe visual impairment.ā
– World Health Organisation
Solution
CheckEye has developed a cloud-based solution to detect diabetic retinopathy using photographic images of eye fundus through the ML\AI algorithm. Photographs can be taken anywhere – from optic retailers to pharmacies – by non-medical staff to be further uploaded to the system for diagnosis. CheckEye will make early detection of diabetic retinopathy and retinopathy prevention easily accessible for all.
Who benefits?
The public health and economic benefits of early detection, prevention and treatment of diabetic retinopathy are immense.
PATIENTS
REDUCED WAITING TIME
Reduced waiting time to access professional treatment by receiving quick and accurate retinopathy screening test results in a wide network of locations.
BETTER COST EFFICIENCY
More cost effective treatment of diabetic retinopathy
TIMELY TREATMENT
Early detection and timely treatment of diabetic retinopathy in people living with diabetes.
BETTER VISION FOR LIFE
Mitigated risk of developing a severe case of retinopathy and blindness.
EYE HEALTH PROFESSIONALS
MORE QUALITY TIME WITH PATIENTS
Increased efficiency of a specialistās performance through freeing up time with Mobile Diabetic Retinopathy Screening which is otherwise invested in conducting routine screenings.
ACCURATE DIAGNOSIS
More accurate diagnosis through better quality of screening images achieved with AI-based technology
BETTER PERFORMANCE RESULTS
Higher rate of appointments for patients with screen-positive results who require treatment more urgently.
PUBLIC HEALTH SYSTEMS & INSURANCE COMPANIES
BETTER ACCESS TO SCREENING
Lowering the barriers for access and the cost of systematic Diabetic Eye Screening TestĀ reduces disease burden on the public health and social care systems.
LESS FINANCIAL BURDEN
Early Detection of Diabetic Retinopathy brings down the cost of treatment timefold.
MORE ACCURATE SCREENING RESULTS
Automated image analysis systems provide a more accurate diagnosis compared to the manual grading, thus allowing to prioritise patients for treatment based on the severity of their condition.
LESS ADMIN WORK FOR MEDICAL PERSONNEL
Where there are staff shortages and/or limited access to treatments, the system prioritises patients automatically based on the severity of their condition.
Our team
CheckEye operates an international team based in the UK, Ukraine and Switzerland. Our shared credentials include decades of senior level experience across IT, telecom and health industries in global brands, higher education in the world’s best universities, and a profound understanding of the rapidly evolving healthcare trends globally.
Kirill Goncharuk,
CEO
Kirill is a senior IT professional with two decades of technology and IT product development experience. His role at CheckEye encompasses both general management and product development, underpinned by expertise gained across Kirillās work in large corporates in information technology & security and business continuity roles across industries – energy, system integration and telecom. Kirill has been on the senior leadership teams in Ukraineās largest names such as VEON, DTEK, and currently Ukrtelecom.
Kirill is a candidate for Global Executive MBA from IESE Business School, University of Navarra.
Dmitry Sofyna,Ā
CTO
Dmitry is the head of the Artificial Intelligence Research and Development Center. He has over 10 years of experience in analyzing business needs and developing digital solutions. Prior to this, he worked in the field of finance and banking. He holds two higher education degrees. He is the founder and Chairman of the Supervisory Board of the Vinnytsia IT Association. He is also the founder of the UME ecosystem for learning and work. He is the author of the Country’s Digital Transformation concept.
Andrii Korol,
Medical AdvisorĀ
Andrii is a Doctor of Medical Sciences, Senior Researcher, Head of the Department of Studying the Biological Action and Application of Lasers in Ophthalmology of the āThe Filatov Institute of Eye Diseases and Tissue Therapy of the National Academy of Medical Sciences of Ukraineā, specialisation in ophthalmology: diagnosis of fundus diseases, laser microsurgery, treatment of fundus diseases using antiangiogenic factors. Author of 39 scientific articles in international journals included in the Scopus scientometric database, two monographs, scientific supervisor of three dissertations.
Member of the Ukrainian Society of Ophthalmologists, European Society of Retina Specialists –Ā EURETINA, International Expert Group of Vision Academy.
Michael Shuranov, Communications Advisor
Michael is a senior communications professional bringing over 20 years of hands-on experience in public relations and reputation management. Having worked in senior communications roles in large corporates across food, retail and telecom including McDonaldās, Avon, VEON and currently Ukrtelecom, the largest telco in Ukraine, Michael advises CheckEye on the high level strategic positioning and comm steam design.
Michael teaches Media Relations at the Chartered Institute of Public Relations, Ukraine.
Daria Partas,
Head of Communications
Daria is a London-based strategic communications advisor and reputation management expert with over 15 years of experience. Daria’s career includes working in communication roles in/with complex matrix cross-border organisations such as BT, VEON, United Nations, and CNN International. With over 15 years of experience in international communications, she is responsible for developing the brand vision, core positioning and global communications strategies for CheckEye.
Daria graduated with an MA in Digital Culture and Society from Kingās College London. She holds a CIPR Professional PR Diploma from Londonās PR Academy and a Certificate in Analyst Relations from Forrester.
News
The sharp edge of diabetes begins when it’s still undetected!
In today's world, diabetes is becoming increasingly noticeable, but the most concerning scenario is undiagnosed diabetes ā a silent hijacker of health, waiting for its chance to attack the human body. Statistics indicate that the risk group for diabetes includes not...
Updated standards of diabetes treatment 2024
Recently, the American Diabetes Association (ADA) introduced updated recommendations for diabetes treatment standards in 2024, considering expert conclusions and new scientific discoveries. Last year, the standards focused on an individualized approach and advanced...
Uniting with the International Diabetes Federation to combat Type 2 diabetes
Recent events at the international level indicate growing attention to the issue of Type 2 diabetes (T2D) and the importance of raising awareness and advocacy in this field. Individuals with Type 2 diabetes (T2D) are partially subjected to stigma, often associated...
Our first article has been published in the Ophthalmology Journal!
"Detecting diabetic retinopathy using an artificial intelligence-based software platform: a pilot study" This publication is the result of collaborative efforts between the CheckEye team and leading experts from the Filatov Institute, Komisarenko Institute of...
CheckEye was selected as Tech Fair Winners at the Advanced Technologies & Treatments for Diabetes (ATTD) 2024
CheckEye was selected as Tech Fair Winners at the Advanced Technologies & Treatments for Diabetes (ATTD) 2024 conference in Florence, Italy, last week. Our Healthcare Advisor, Olena Chernenko, represented CheckEye at this prestigious conference focused on...
Recent research on diabetic retinopathy treatment: effective methods for preserving vision
After receiving a conclusion regarding the presence of signs of diabetic retinopathy (DR) and a final diagnosis from an ophthalmologist, the choice of treatment method depends on the stage of the disease. For instance, in the early stages of DR, glycemic control and...
Risks of developing diabetes and prospects for different age groups
Until recently, Type 2 diabetes mellitus (DM) was considered a disease of the elderly; however, recent research indicates that this issue is becoming relevant across a broader age spectrum, including teenagers and children. The CheckEye team has gathered and analyzed...
CheckEye and Zakarpattia EndoClinic, under the leadership of experienced physician and candidate of medical sciences Olha Oleksyk, are implementing a true revolution in endocrinology!
Our joint mission is the implementation of preventive medicine. Our ongoing project, which has been running for over half a year, is to reduce disability among diabetic patients and relieve medical staff from excessive burdens. Currently, we are actively using our...
CheckEye at CES 2024: Part of the Ukrainian Delegation
Just touched down after an electrifying experience atĀ #CES2024Ā in Las Vegas, and the excitement is still buzzing! CES was a mind-blowing journey into the future. From groundbreaking innovations to the latest trends, it set the pulse for tech in the year...
Healthy future – Italian scenario and the path of Ukraine
Protecting our health is a fundamental task for each of us. However, are we all ā from the state to the individual citizen ā doing everything possible for this? Italy has recently set an example for the world by implementing a national screening program for diabetes...
Partners
